Browse
Prediction results retrieved after performance evaluation of WHO approved 34 primers to estimate their binding affinities for 3892 SARS-CoV-2 variants.

Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used
  
B.1.479NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
B.1.1.437NYoung-NCTCAGTCCAAGATGGTATTTCT2240.912858328604F-21953.9Singapore
B.1.1.437NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
B.1.371NYoung-NCTCAGTCCAAGATGGTATTTCT2240.912858328604F-21953.9Singapore
B.1.371NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
B.4.4NYoung-NCTCAGTCCAAGATGGTATTTCT2240.912858328604F-21953.9Singapore
B.4.4NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
FY.6.1NYoung-NCTCAGTCCAAGATGGTATTTCT2240.912858328604F-21953.9Singapore
FY.6.1NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
XBB.1.5.66NYoung-NCTCAGTCCAAGATGGTATTTCT2240.912858328604F-21953.9Singapore
XBB.1.5.66NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
XBB.1.5.4NYoung-NCTCAGTCCAAGATGGTATTTCT2240.912858328604F-21953.9Singapore
XBB.1.5.4NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
EG.1.7NYoung-NCTCAGTCCAAGATGGTATTTCT2240.912858328604F-21953.9Singapore
EG.1.7NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
GS.2NYoung-NCTCAGTCCAAGATGGTATTTCT2240.912858328604F-21953.9Singapore
GS.2NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
B.1.258.17NYoung-NCTCAGTCCAAGATGGTATTTCT2240.912858328604F-21953.9Singapore
B.1.258.17NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
BA.1.21.1NYoung-NCTCAGTCCAAGATGGTATTTCT2240.912858328604F-21953.9Singapore
BA.1.21.1NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
BF.21NYoung-NCTCAGTCCAAGATGGTATTTCT2240.912858328604F-21953.9Singapore
BF.21NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
FK.1.3.2NYoung-NCTCAGTCCAAGATGGTATTTCT2240.912858328604F-21953.9Singapore
FK.1.3.2NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
XBFNYoung-NCTCAGTCCAAGATGGTATTTCT2240.912858328604F-21953.9Singapore
XBFNYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
BA.5.6NYoung-NCTCAGTCCAAGATGGTATTTCT2240.912858328604F-21953.9Singapore
BA.5.6NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
BF.11.5NYoung-NCTCAGTCCAAGATGGTATTTCT2240.912858328604F-21953.9Singapore
BF.11.5NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
XBF.7.1NYoung-NCTCAGTCCAAGATGGTATTTCT2240.912858328604F-21953.9Singapore
XBF.7.1NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
FY.5.3NYoung-NCTCAGTCCAAGATGGTATTTCT2240.912858328604F-21953.9Singapore
FY.5.3NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
FP.2.1.1NYoung-NCTCAGTCCAAGATGGTATTTCT2240.912858328604F-21953.9Singapore
FP.2.1.1NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
XBB.2.9NYoung-NCTCAGTCCAAGATGGTATTTCT2240.912858328604F-21953.9Singapore
XBB.2.9NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
FL.2.2NYoung-NCTCAGTCCAAGATGGTATTTCT2240.912858328604F-21953.9Singapore
FL.2.2NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
JW.1NYoung-NCTCAGTCCAAGATGGTATTTCT2240.912858328604F-21953.9Singapore
JW.1NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
FY.4NYoung-NCTCAGTCCAAGATGGTATTTCT2240.912858328604F-21953.9Singapore
FY.4NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
B.1.497NYoung-NCTCAGTCCAAGATGGTATTTCT2240.912858328604F-21953.9Singapore
B.1.497NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
EN.1.1NYoung-NCTCAGTCCAAGATGGTATTTCT2240.912858328604F-21953.9Singapore
EN.1.1NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
AY.30 (Delta)NYoung-NCTCAGTCCAAGATGGTATTTCT2240.912858328604F-21953.9Singapore
Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used